MAPT and Alzheimer disease: However, some authors examine α-syn protein in the neurodegeneration process of AD and propose to consider cerebrospinal fluid (CSF) α-syn as a possible additional biomarker to the so-called “core” of AD (Aβ42, T-tau and p-tau181p).